Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 29, 2015 4:38 AM ET

Company Overview of United States Food and Drug Administration

Company Overview

158-15 Liberty Avenue

Jamaica, NY 

United States



Key Executives for United States Food and Drug Administration

Age: 60
Associate Commissioner for Policy and Planning
Director of New Psychiatry Products Division
Principal Deputy Commissioner and Chief Scientist
Deputy Commissioner of Foods
Compensation as of Fiscal Year 2015.

United States Food and Drug Administration Key Developments

U.S. Food and Drug Administration Appoints Theodore P. Labuza as New Member of the Food Advisory Committee

The Institute of Food Technologists announced that IFT Past President Theodore P. Labuza, PhD has been appointed as a new member of the Food Advisory Committee of the FDA. IFT nominated Dr. Labuza for this position. Dr. Labuza is the Morse Alumni Distinguished Teaching Professor of Food Science and Engineering in the Department of Food Science and Nutrition at the University of Minnesota. Dr. Labuza will serve a term beginning immediately and ending June 30, 2019. In this capacity, he will provide advice to the Commissioner of Food and Drugs and other appropriate officials, on emerging food safety, food science, nutrition, and other food-related health issues that the FDA considers of primary importance for its food and cosmetics programs.

United States Food and Drug Administration Presents at UBS Genomics 2.0 Summit, Aug-13-2015 01:15 PM

United States Food and Drug Administration Presents at UBS Genomics 2.0 Summit, Aug-13-2015 01:15 PM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: David Litwack, Policy Advisor.

Alphatec Spine, Inc. Receives Warning Letter from U.S. Food and Drug Administration in Connection with the FDA's Inspection of the Company's Manufacturing Facilities Located in Carlsbad, CA

On July 17, 2015, Alphatec Spine, Inc. received a warning letter, dated July 16, 2015, from the U.S. Food and Drug Administration (FDA) in connection with the FDA's inspection of the company's manufacturing facilities located in Carlsbad, CA that occurred from February 4, 2015 until March 13, 2015. In the warning letter, the FDA cited eight deficiencies in the company's responses to the FDA Form 483, Inspectional Observations, which was issued to the company at the end of the Inspection. The deficiencies relate to the company's internal procedures for quality planning, design control, document control and corrective and preventive actions. The warning letter does not restrict production or shipment of the company's products from its facilities, or the sale or marketing of the company's products. The company is currently addressing the deficiencies cited by the FDA in the warning letter and intends to work closely with the FDA to resolve any outstanding issues. Until the procedures noted in the warning letter are corrected, the company may be subject to additional regulatory action by the FDA, and any such actions could significantly disrupt the company's ongoing business and operations and have a material adverse impact on the company's financial position and operating results.

Similar Private Companies By Industry

Company Name Region
FlightSafety International Inc. United States
Old World Provisions, Inc. United States
DCBC Inc. United States
Global Sales Alliance United States
Sym-Tek Systems, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact United States Food and Drug Administration, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at